Literature DB >> 19200345

Prostaglandin E2 modulates Na+,K+-ATPase activity in rat hippocampus: implications for neurological diseases.

Mauro Schneider Oliveira1, Ana Flávia Furian, Leonardo Magno Rambo, Leandro Rodrigo Ribeiro, Luiz Fernando Freire Royes, Juliano Ferreira, João Batista Calixto, Luis Fernando Pacheco Otalora, Emilio Rafael Garrido-Sanabria, Carlos Fernando Mello.   

Abstract

Prostaglandin E(2) (PGE(2)) is quantitatively one of the major prostaglandins synthesized in mammalian brain, and there is evidence that it facilitates seizures and neuronal death. However, little is known about the molecular mechanisms involved in such excitatory effects. Na(+),K(+)-ATPase is a membrane protein which plays a key role in electrolyte homeostasis maintenance and, therefore, regulates neuronal excitability. In this study, we tested the hypothesis that PGE(2) decreases Na(+),K(+)-ATPase activity, in order to shed some light on the mechanisms underlying the excitatory action of PGE(2). Na(+),K(+)-ATPase activity was determined by assessing ouabain-sensitive ATP hydrolysis. We found that incubation of adult rat hippocampal slices with PGE(2) (0.1-10 microM) for 30 min decreased Na(+),K(+)-ATPase activity in a concentration-dependent manner. However, PGE(2) did not alter Na(+),K(+)-ATPase activity if added to hippocampal homogenates. The inhibitory effect of PGE(2) on Na(+),K(+)-ATPase activity was not related to a decrease in the total or plasma membrane immunocontent of the catalytic alpha subunit of Na(+),K(+)-ATPase. We found that the inhibitory effect of PGE(2) (1 microM) on Na(+),K(+)-ATPase activity was receptor-mediated, as incubation with selective antagonists for EP1 (SC-19220, 10 microM), EP3 (L-826266, 1 microM) or EP4 (L-161982, 1 microM) receptors prevented the PGE(2)-induced decrease of Na(+),K(+)-ATPase activity. On the other hand, incubation with the selective EP2 agonist (butaprost, 0.1-10 microM) increased enzyme activity per se in a concentration-dependent manner, but did not prevent the inhibitory effect of PGE(2). Incubation with a protein kinase A (PKA) inhibitor (H-89, 1 microM) and a protein kinase C (PKC) inhibitor (GF-109203X, 300 nM) also prevented PGE(2)-induced decrease of Na(+),K(+)-ATPase activity. Accordingly, PGE(2) increased phosphorylation of Ser943 at the alpha subunit, a critical residue for regulation of enzyme activity. Importantly, we also found that PGE(2) decreases Na(+),K(+)-ATPase activity in vivo. The results presented here imply Na(+),K(+)-ATPase as a target for PGE(2)-mediated signaling, which may underlie PGE(2)-induced increase of brain excitability.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19200345     DOI: 10.1111/j.1471-4159.2009.05961.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  11 in total

1.  Regulation of Neuronal Na+/K+-ATPase by Specific Protein Kinases and Protein Phosphatases.

Authors:  Sandesh Mohan; Manindra Nath Tiwari; Yoav Biala; Yoel Yaari
Journal:  J Neurosci       Date:  2019-05-13       Impact factor: 6.167

2.  Exercise pre-conditioning reduces brain inflammation and protects against toxicity induced by traumatic brain injury: behavioral and neurochemical approach.

Authors:  Bibiana Castagna Mota; Leticia Pereira; Mauren Assis Souza; Luiz Fernando Almeida Silva; Danieli Valnes Magni; Ana Paula Oliveira Ferreira; Mauro Schneider Oliveira; Ana Flávia Furian; Leidiane Mazzardo-Martins; Morgana Duarte da Silva; Adair Roberto Soares Santos; Juliano Ferreira; Michele Rechia Fighera; Luiz Fernando Freire Royes
Journal:  Neurotox Res       Date:  2011-07-07       Impact factor: 3.911

3.  Protein kinase A (PKA) phosphorylation of Na+/K+-ATPase opens intracellular C-terminal water pathway leading to third Na+-binding site in molecular dynamics simulations.

Authors:  Hanne Poulsen; Poul Nissen; Ole G Mouritsen; Himanshu Khandelia
Journal:  J Biol Chem       Date:  2012-03-20       Impact factor: 5.157

4.  Systemic delivery of selective EP1 and EP3 receptor antagonists attenuates pentylenetetrazole-induced seizures in mice.

Authors:  Cristina R Reschke; Alice B Poersch; Cíntia J Masson; Ana C Jesse; Joseane R Marafiga; Quéli F Lenz; Mauro S Oliveira; David C Henshall; Carlos F Mello
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2018-03-10

5.  Prostaglandins of the E series inhibit monoamine release via EP3 receptors: proof with the competitive EP3 receptor antagonist L-826,266.

Authors:  J Günther; K Schulte; D Wenzel; B Malinowska; E Schlicker
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2009-12-10       Impact factor: 3.000

6.  Adeno-Associated Virus-Mediated Gene Therapy in the Mashlool, Atp1a3Mashl/+, Mouse Model of Alternating Hemiplegia of Childhood.

Authors:  Arsen S Hunanyan; Boris Kantor; Ram S Puranam; Courtney Elliott; Angela McCall; Justin Dhindsa; Promila Pagadala; Keri Wallace; Jordan Poe; Talha Gunduz; Aravind Asokan; Dwight D Koeberl; Mai K ElMallah; Mohamad A Mikati
Journal:  Hum Gene Ther       Date:  2021-02-12       Impact factor: 5.695

7.  N-acetylcysteine prevents spatial memory impairment induced by chronic early postnatal glutaric acid and lipopolysaccharide in rat pups.

Authors:  Fernanda S Rodrigues; Mauren A Souza; Danieli V Magni; Ana Paula O Ferreira; Bibiana C Mota; Andreia M Cardoso; Mariana Paim; Léder L Xavier; Juliano Ferreira; Maria Rosa C Schetinger; Jaderson C Da Costa; Luiz Fernando F Royes; Michele R Fighera
Journal:  PLoS One       Date:  2013-10-24       Impact factor: 3.240

8.  Epinephrine modulates Na+/K+ ATPase activity in Caco-2 cells via Src, p38MAPK, ERK and PGE2.

Authors:  Layla El Moussawi; Mohamed Chakkour; Sawsan I Kreydiyyeh
Journal:  PLoS One       Date:  2018-02-21       Impact factor: 3.240

9.  Eplerenone repolarizes muscle membrane through Na,K-ATPase activation by Tyr10 dephosphorylation.

Authors:  Simon Breitenbach; Frank Lehmann-Horn; Karin Jurkat-Rott
Journal:  Acta Myol       Date:  2016-10

10.  The epinephrine-induced PGE2 reduces Na+/K+ ATPase activity in Caco-2 cells via PKC, NF-κB and NO.

Authors:  Layla El Moussawi; Mohamed Chakkour; Sawsan Kreydiyyeh
Journal:  PLoS One       Date:  2019-08-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.